Physician Wealth Advisors’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Other funds holding FULC
Physician Wealth Advisors's FULC Position: Q3 2026 in Review
Physician Wealth Advisors opened a new position in Fulcrum Therapeutics (FULC) in Q3 2026: 130 shares worth $481. The stake represents ﹤0.01% of the portfolio and ranks #2276 among its holdings. This is a return to the name: Physician Wealth Advisors previously reported a position in FULC as recently as Q1 2026.
Physician Wealth Advisors first reported a position in FULC in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.2K in Q4 2025. 151 funds tracked by Wall St. Rank hold FULC as of Q3 2026.
- Physician Wealth Advisors held 130 shares of Fulcrum Therapeutics worth $481 as of Q3 2026.
- Fulcrum Therapeutics was a new Physician Wealth Advisors position in Q3 2026.
- Fulcrum Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2276 holding.
- Physician Wealth Advisors first reported a position in Fulcrum Therapeutics in Q2 2025 and has held it in 5 quarters since.
- Physician Wealth Advisors's Fulcrum Therapeutics position peaked at $3.2K in Q4 2025.
- 151 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.
Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.